Results 81 to 90 of about 6,214,933 (159)
INTRODUCTION:Ceroid lipofuscinosis neuronal 2 (CLN2) disease, a form of Batten disease, is a rare, degenerative neurometabolic disorder. Disease onset around 2–4 years is followed by rapid decline in motor and neurologic function and mortality in early ...
Andrea West +7 more
core +1 more source
Although a disease-modifying therapy for classic late infantile neuronal ceroid lipofuscinosis (CLN2 disease) exists, poor understanding of cellular pathophysiology has hampered the development of more effective and persistent therapies.
Keigo Takahashi +10 more
doaj +1 more source
A class of progressive, autosomal recessive neurodegenerative diseases known as neuronal ceroid lipofuscinoses (NCLs) are brought on by lysosomal protein or enzyme dysfunction.
Anna Bryzik +4 more
doaj +1 more source
Neuronal ceroid lipofuscinosis type 2 (CLN2) is a rapidly progressive neurodegenerative disorder leading to premature mortality. Ambulatory CLN2 patients typically receive standard of care treatment through biweekly intracerebroventricular (ICV) enzyme ...
Rahul Soangra +3 more
doaj +1 more source
Flupirtine derivatives as potential treatment for the neuronal ceroid lipofuscinoses
Objective Neuronal Ceroid Lipofuscinoses (NCL) are fatal inherited neurodegenerative diseases with established neuronal cell death and increased ceramide levels in brain, hence, a need for disease‐modifying drug candidates, with potential to enhance ...
Joelle Makoukji +7 more
doaj +1 more source
Neuronal ceroid lipofuscinoses (NCLs) are a growing group of neurodegenerative storage diseases, in which specific features are sought to facilitate the creation of a universal diagnostic algorithm in the future. In our ultrastructural studies, the group
Paulina Felczak +5 more
doaj +1 more source
Evolution of Movement Disorders in Patients With CLN2-Batten Disease Treated With Enzyme Replacement Therapy [PDF]
OBJECTIVES: Neuronal ceroid lipofuscinosis type 2 (CLN2-disease) is an inherited childhood-onset neurodegenerative condition, with classical early features of speech delay, epilepsy, myoclonus, ataxia, and motor regression.
Soo, Audrey K +8 more
core +1 more source
Limited research has investigated the challenges faced by families caring for children with neuronal ceroid lipofuscinosis type 2 (CLN2) disease. Face-to-face, mixed-method, in-depth surveys were conducted with 19 families (23 children) in the UK (n=9 ...
Angela Schulz +10 more
doaj +1 more source
G1-faasi tsükliinist sõltuva kinaasi kompleksi Cln2-Cdk1 substraatide valiku mehhanismid [PDF]
Saccharomyces cerevisiae Cdk1 reguleerib erinevate valkude fosforüleerimise kaudu kogu rakutsükli toimimist. Eri aegadel seondub Cdk1 erinevate tsükliinidega. Mitmed Cdk1 substraadid on enim fosforüleeritud G1-faasis, mil Cdk1 on kompleksis tsükliiniga
Örd, Mihkel
core
Speech, Language and Non‐verbal Communication in
ABSTRACT CLN2 and CLN3 diseases, the most common types of Batten disease (also known as neuronal ceroid lipofuscinosis), are childhood dementias associated with progressive loss of speech, language and feeding skills.
Lottie D. Morison +9 more
openaire +2 more sources

